A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)
Clinical trial NCT01756079 · COMPLETED
Trial details
- NCT number
- NCT01756079
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-06
- Primary completion
- 2015-11-17
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.